For example, NK cells in prostate cancer patients showed a decreased level of activating receptors, such as NKp46, NKp30, DNAM1 and CD16, and an increased level of inhibitory receptors, such as ILT2. The gene discussed is NCR1; the disease is Familial prostate cancer.